Insider Trading History of Soloway Thomas P

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Soloway Thomas P since 2011. The trader's CIK number is 1454280. At the time of the last reporting, Soloway Thomas P was the SVP, Operations and CFO of Audentes Therapeutics, Inc.. (stock ticker symbol BOLD). Also see all insider trading activities at Audentes Therapeutics, Inc..

Note that in the past Soloway Thomas P also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (TSPT) by Soloway Thomas P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 TSPT 0 $0 76,270 $633,392 76,270 $148,125

Yearly summary of insider trading at Audentes Therapeutics, Inc. (BOLD) by Soloway Thomas P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 BOLD 0 $0 0 $0 150,888 $1,359,802
2019 BOLD 0 $0 0 $0 41,321 $114,252


Insider trading activities at 2 companies by Soloway Thomas P:

1. Paratek Pharmaceuticals, Inc. (TSPT)

2. Audentes Therapeutics, Inc. (BOLD)

Table 1. Insider trading of Paratek Pharmaceuticals, Inc. (TSPT) by Soloway Thomas P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-12-01 TSPT Sale 62,670 8.40 526,428
2011-12-01 TSPT Option Ex 62,670 1.78 111,677
2011-11-23 TSPT Sale 13,600 7.87 106,964
2011-11-23 TSPT Option Ex 13,600 2.68 36,448

Table 2. Insider trading of Audentes Therapeutics, Inc. (BOLD) by Soloway Thomas P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-01-08 BOLD Option Ex 150,888 9.01 1,359,802
2019-12-12 BOLD Option Ex 41,321 2.77 114,252

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Soloway Thomas P (SVP, Operations and CFO of Audentes Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.